Biomarker Profiles in Trastuzumab (T) Refractory HER2+ Inflammatory Breast Cancer (IBC) That Predict for Survival Benefit from Lapatinib (L) Monotherapy.
暂无分享，去创建一个
C. Swanton | S. Stein | S. Johnston | M. Trudeau | B. Kaufman | V. Salazar | R. Gagnon | Yao-bin Liu | Anne-Marie Martin